Proteinase-activated receptor-2 (PAR2): A tumor suppressor in skin carcinogenesis

Journal of Investigative Dermatology

Volumn 127, Issue 9, 2007, Pages 2245-2252

  Rattenholl, Anke ^a   Seeliger, Stephan ^a   Buddenkotte, Jörg ^a   Schön, Margarete ^b,c   Schön, Michael P ^b,c   Ständer, Sonja ^a   Vergnolle, Nathalie ^d   Steinhoff, Martin ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEINASE ACTIVATED RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL INVASION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; KERATINOCYTE; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SKIN TUMOR; TRANSACTIVATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL LINE, TUMOR; EPIDERMIS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; KERATINOCYTES; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; RECEPTOR, PAR-2; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TRANS-ACTIVATION (GENETICS); TRANSFORMING GROWTH FACTOR BETA1;

EID: 34547868524     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700847     Document Type: Article

References (38)

1. Algermissen B, Sitzmann J, Nürnberg W, Laubscher JC, Henz BM, Bauer F (2000) Distribution and potential biologic function of the thrombin receptor PAR-1 on human keratinocytes. Arch Dermatol Res 292: 488-95
2. Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A (2005) PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120:303-13
3. Cottrell GS, Amadesi S, Grady EF, Bunnett NW (2004) Trypsin IV, a novel agonist of protease-activated receptors 2 and 4. J Biol Chem 279:13532-9
4. Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z et al. (1999) Inflammatory mast cells up-regulate angiogenesis during squamous cell epithelial carcinogenesis. Genes Dev 13:1382-97
5. Dahler AL, Cavanagh LL, Saunders NA (2001) Suppression of keratinocyte growth and differentiation by transforming growth factor beta1 involves multiple signaling pathways. J Invest Dermatol 116:266-74
6. Darmoul D, Gratio V, Devaud H, Laburthe M (2004) Protease-activated receptor 2 in colon cancer: trypsin induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation. J Biol Chem 279:20927-34
7. Derian CK, Eckhardt AJ, Andrade-Gordon P (1997) Differential regulation of human keratinocyte growth and differentiation by a novel family of protease-activated receptors. Cell Growth Differ 8:743-9
8. Elmets CA, Athar M, Tubesing KA, Rothaupt D, Xu H, Mukhtar H (1998) Susceptibility to the biological effects of polyaromatic hydrocarbons is influenced by genes of the major histocompatibility complex. Proc Natl Acad Sci USA 95:14915-9
9. Ge L, Shenoy SK, Lefkowitz RJ, DeFea KA (2004) Constitutive protease-activated-receptor-2 mediated migration of MDA MB-231 breast cancer cells requires both β-arrestin-1 and 2. J Biol Chem 279:55419-24
10. Hjortoe GM, Petersen LC, Albrektsen T, Sorensen BB, Norby PL, Mandal SK et al. (2004) Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB231 cells is mediated by PAR-2 and results in increased cell migration. Blood 103:3029-37
11. Hou L, Kapas S, Cruchley AT, Macey MG, Harriott P, Chinni C et al. (1998) Immunolocalization of protease-activated receptor-2 in skin: receptor activation stimulates interleukin-8 secretion by keratinocytes in vitro. Immunology 94:356-62
12. Huitfeldt HS, Heyden A, Clausen OP, Thrane EV, Roop D, Yuspa SH (1991) Altered regulation of growth and expression of differentiation-associated keratins in benign mouse skin tumors. Carcinogenesis 12:2063-7
13. Jeon GA, Lee JS, Patel V, Gutkind JS, Thorgeirsson SS, Kim EC et al. (2004) Global gene expression profiles of human head and neck squamous cell carcinoma cell lines. Int J Cancer 112:249-58
14. Jikuhara A, Yoshii M, Iwagaki H, Mori S, Nishibori M, Tanaka N (2004) MAP kinase-mediated proliferation of DLD-1 carcinoma by the stimulation of protease-activated receptor-2. Life Sci 73:2817-29
15. Kaufmann R, Schafberg H, Nowak G (1998) Proteinase-activated receptor-2-mediated signaling and inhibition of DNA synthesis in human pancreatic cancer cells. Int J Pancreatol 24:97-102
16. Liu Y, Mueller BM (2006) Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways. Biochem Biophys Res Comm 344:1263-70
17. 2. J Pharmacol Exp Ther 303:985-92
18. Mehrel T, Hohl D, Rothnagel JA, Longley MA, Bundman D, Cheng C et al. (1990) Identification of a major keratinocate cell envelope protein, loricrin. Cell 61:1103-12
19. Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N et al. (1999) Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nat Med 5:828-31
20. Okamoto T, Nishibori M, Sawada K, Iwagaki H, Nakaya N, Jikuhara A et al. (2001) The effects of stimulating protease-activated receptor-1 and -2 in A172 human glioblastoma. J Neural Transm 108:125-40
21. Ossovskaya VS, Bunnett NW (2004) Protease-activated receptors: contribution to physiology and disease. Physiol Rev 81:579-621
22. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C et al. (1999) EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402: 884-8
23. Rattenholl A, Steinhoff M (2003) Role of proteinase-activated receptors in cutaneous biology and disease. Drug Dev Res 59:408-16
24. Reichelt J, Furstenberger G, Magin TM (2004) Loss of keratin 10 leads to mitogen-activated protein kinase (MAPK) activation, increased keratinocyte turnover, and decreased tumor formation in mice. J Invest Dermatol 123:973-81
25. Roy SS, Safeddine M, Loutzenhiser R, Tiggle CR, Hollenberg MD (1998) Dual endothelium-dependent vascular activities of proteinase-activated receptor-2 activating peptides: evidence for receptor heterogeneity. Br J Pharmacol 123:1434-40
26. Sabri A, Short J, Guo J, Steinberg SF (2002) Protease-activated receptor-1-mediated DNA synthesis in cardiac fibroblast is via epidermal growth factor receptor transactivation: distinct PAR-1 signaling pathways in cardiac fibroblasts and cardiomyocytes. Circ Res 91:532-9
27. Santos M, Paramio JM, Bravo A, Ramirez, Jorcano JL (2002) The expression of keratin k10 in the basal layer of the epidermis inhibits cell proliferation and prevents skin tumorigenesis. J Biol Chem 277: 19122-30
28. Santulli RJ, Derian CK, Darrow AL, Tomko KA, Eckhardt AJ, Seiberg M et al. (1995) Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytes. Proc Natl Acad Sci USA 92:9151-5
29. Schön MP, Wienrich BG, Drewniok C, Bong AB, Eberle J, Geilen CC et al. (2004) Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod. J Invest Dermatol 122:1266-76
30. Shi X, Gangadharan B, Brass LF, Ruf W, Mueller BM (2004) Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. Mol Cancer Res 2:395-402
31. Shimamoto R, Sawada T, Uchima Y, Inoue M, Kimura K, Yamashita Y et al. (2004) A role for protease-activated receptor-2 in pancreatic cancer cell proliferation. Int J Oncol 24:1401-6
32. Steinhoff M, Buddenkotte J, Shpacovitch V, Rattenholl A, Moormann C, Vergnolle N et al. (2005) Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 26:1-43
33. Steinhoff M, Corvera CU, Thoma MS, Kong W, McAlpine BE, Caughey GH et al. (1999) Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol 8:282-94
34. Vincent B, Paitel E, Saftig P, Frobert Y, Hartmann D, De Strooper B et al. (2001) The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem 276:37743-6
35. Wang H, Ubl JJ, Reiser G (2002) Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling. Glia 37:53-63
36. Wilson SR, Gallagher S, Warpeha K, Hawthorne SJ (2004) Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors. Prostate 60:168-74
37. Yamasaki K, Toriu N, Hanakawa Y, Shirakata Y, Sayama K, Takayanagi A et al. (2003) Keratinocyte growth inhibition by high-dose epidermal growth factor is mediated by transforming growth factor beta autoinduction: a negative feedback mechanism for keratinocyte growth. J Invest Dermatol 120:1030-7
38. Yamashita K, Minori K, Inoue H, Mori M, Sidransky D (2003) A tumor-suppressive role for trypsin in human cancer progession. Cancer Res 371:541-8